State of Tennessee, Department of Treasury’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-21,236
Closed -$31K 1560
2019
Q1
$31K Sell
21,236
-2,055
-9% -$4.65K ﹤0.01% 1581
2018
Q4
$60K Hold
23,291
﹤0.01% 1539
2018
Q3
$102K Hold
23,291
﹤0.01% 1524
2018
Q2
$143K Hold
23,291
﹤0.01% 1469
2018
Q1
$170K Hold
23,291
﹤0.01% 1451
2017
Q4
$191K Hold
23,291
﹤0.01% 1478
2017
Q3
$245K Buy
23,291
+5,736
+33% +$54.8K ﹤0.01% 1426
2017
Q2
$194K Buy
+17,555
New +$176K ﹤0.01% 1462

Other funds holding AVDL

State of Tennessee, Department of Treasury's AVDL Position: Q2 2019 in Review

State of Tennessee, Department of Treasury sold out of Avadel Pharmaceuticals (AVDL) in Q2 2019, closing a stake of 21,236 shares — an estimated $31K sold.

State of Tennessee, Department of Treasury first reported a position in AVDL in Q2 2017 and held it in 8 quarters. The position peaked at $245K in Q3 2017. 45 funds tracked by Wall St. Rank hold AVDL as of Q2 2019.

  • State of Tennessee, Department of Treasury reported no remaining Avadel Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 21,236 Avadel Pharmaceuticals shares in Q2 2019, an estimated $31K.
  • State of Tennessee, Department of Treasury first reported a position in Avadel Pharmaceuticals in Q2 2017 and held it in 8 quarters.
  • State of Tennessee, Department of Treasury's Avadel Pharmaceuticals position peaked at $245K in Q3 2017.
  • 45 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q2 2019.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2019, filed 12 Aug 2019.